It has been on my watchlist. The stock crashed a few years ago when two graders had interpreted the same MRI images differently at different points in time. The interpretations had to be redone. The company got into a difficult spiral with financing during the post-covid crash. This is just from memory. But the product is quite niche. Too niche for me. It’s hard to estimate what the market size is, and how good the product really is. Besides, the information on the company’s own website is so scarce / hard to find that I’ll pass.
1 Like